October 31, 2014 6:19 PM ET

Pharmaceuticals

Company Overview of Zacharon Pharmaceuticals, Inc.

Executive Profile

Jeffrey D. Esko Ph.D.

Co-Founder, Chief Scientific Advisor and Director, Zacharon Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Dr. Jeffrey D. Esko, Ph.D. is a Co-Founder of Zacharon Pharmaceuticals, Inc. and serves as its Chief Scientific Advisor. Dr. Esko serves as a Professor at the Department of Cellular and Molecular Medicine at University of California at San Diego. Dr. Esko was the President of the Society for Glycobiology from 2002 to 2003. He had continuous demand for his expertise in glycobiology and has consulted for a number of biotechnology and pharmaceutical companies. He also co-directs ...

Corporate Headquarters

5626 Oberlin Drive
San Diego, California 92121

United States

Phone: 858-459-9750
Fax: 858-459-9756

Board Members Memberships

Co-Founder, Chief Scientific Advisor and Director

Education

PhD
University of Wisconsin - Madison

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Zacharon Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.